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Abstract    
Ion channels represent a large and growing family of target proteins regulated by gasotransmitters 
such as nitric oxide, carbon monoxide and, as described more recently, hydrogen sulfide. Indeed, 
many of the biological actions of these gases can be accounted for by their ability to modulate ion 
channel activity. Here, we report recent evidence that H2S is a modulator of low voltage-activated T-
type Ca2+ channels, and discriminates between the different subtypes of T-type Ca2+ channel in that 
it selectively modulates Cav3.2, whilst Cav3.1 and Cav3.3 are unaffected. At high concentrations, H2S 
augments Cav3.2 currents, an observation which has led to the suggestion that H2S exerts its pro-
nociceptive effects via this channel, since Cav3.2 plays a central role in sensory nerve excitability. 
However, at more physiological concentrations, H2S is seen to inhibit Cav3.2. This inhibitory action 
requires the presence of the redox-sensitive, extracellular region of the channel which is responsible 
for tonic metal ion binding, and which particularly distinguishes this channel isoform from Cav3.1 
and 3.3. Further studies indicate that H2S may act in a novel manner to alter channel activity by 
potentiating the zinc sensitivity / affinity of this binding site. This review discusses the different 
reports of H2S modulation of T-type Ca
2+ channels, and how such varying effects may impact on 
nociception, given the role of this channel in sensory activity. This subject remains controversial, and 
future studies are required before the impact of T-type Ca2+ channel modulation by H2S might be 
exploited as a novel approach to pain management. 
 
Abbreviations:   
BKCa, Large conductance K
+ channel; CAT, cysteine aminotransferase; CBS, cystathionine β synthase; 
CSE, cystathionine γ lyase; DAO, D-amino acid oxidase; DRG neuron, dorsal root ganglion neuron; 
DTT, dithiothreitol; HEK293 cells, KATP, ATP-sensitive K
+ channel; human embryonic kidney cells; 
LTMR, low threshold mechanoreceptor; MCO, metal-catalysed oxidation; 3-MST, 3-
mercaptopyruvate sulfurtransferase; NMDAR, N-methyl-D-aspartate receptor; RMP, resting 
membrane potential; TPEN, N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine; TRP, Transient 
receptor potential channels.  
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Introduction 
Ion channel activity is central to a vast and diverse array of cellular functions in both excitable and 
non-excitable cell types. They control, for example, gene expression, apoptosis, proliferation, 
contractility, fluid transport, exocytosis, excitability and action potential propagation. It is therefore 
unsurprising that the number of genes encoding ion channel proteins (either the pore-forming 
proteins or auxiliary subunits) runs into the hundreds. This diversity is further increased by splice 
variation and also the fact that subunits of different channel types can form functional channels by 
combining with other (albeit related) subunits to form heteromeric complexes. Of the many 
functions regulated by ion channels one of the most important is the control of [Ca2+]i as this ion is a 
ubiquitous intracellular signalling molecule that mediates many of the ways in which channels 
influence the above-mentioned fundamental cellular functions (Berridge et al., 2003;Clapham, 
2007). Here, we discuss recently discovered new modes of regulation of one specific class of Ca2+ 
channel, the voltage-gated T-type Ca2+ channel.   
Tailoring ion channel activity to serve specific and often co-ordinated roles requires not only the 
availability of multiple channel types, but also that they can be dynamically regulated. This can occur 
by a plethora of means; for example by coupling to specific G-proteins and via numerous post-
translational modifications including phosphorylation, ubiquitination, sumoylation, nitrosylation, 
sulfhydration and S-acylation (Rajan et al., 2005;Lipscombe et al., 2013;Gonzalez et al., 
2009;Mustafa et al., 2011;Shipston, 2014). Such modifications can regulate ion channel trafficking 
and membrane insertion, as well as ongoing activity. In recent years, it has become apparent that 
ion channels are also modulated by endogenously generated, biologically active gases, often termed 
gasotransmitters; such as nitric oxide, carbon monoxide and hydrogen sulfide (NO, CO and H2S 
respectively). The roles of these gases, especially NO, in diverse physiological and pathological 
settings have in many instances been long-established, but the concept that they represent a new 
class of ion channel regulators is currently emerging (Wilkinson & Kemp, 2011;Peers et al., 
2012;Peers et al., 2014). In this article, we focus on H2S specifically as a modulator of voltage-gated 
T-type Ca2+ channels.  
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T-type Ca2+ channels 
When first described at the single channel level, this class of voltage-gated Ca2+ channel was named 
“T-type” since members had a relatively tiny conductance and gave rise to transient currents 
(Nowycky et al., 1985). These channels are also distinguished from other voltage-gated Ca2+ channels 
by their rapid activation, slow deactivation and very negative activation thresholds, as low as -60mV 
or even below (Carbone & Lux, 1984;Perez-Reyes, 2003;Iftinca & Zamponi, 2009). Example currents 
are shown in Fig. 1A, and a typical current-voltage relationship is presented in Fig. 1B. Owing to this 
low threshold for activation, they also may display a significant window current (i.e. display tonic 
activity; Fig. 1C, arrowed) at potentials close to the resting membrane potential (RMP), and so can 
provide a sustained route for Ca2+ entry into resting cells (exemplified in Fig. 1D) and also contribute 
to setting the RMP (Perez-Reyes, 2003). Three genes, CACNA1G, CACNA1H and CACNA1I give rise to 
pore-forming -subunits of T-type Ca2+ channels, which are nowadays referred to respectively as 
Cav3.1-3.3 (Catterall et al., 2005), with Cav3.3 showing relatively slower activation and inactivation 
kinetics than Cav3.1 or Cav3.2 (Fig. 1A). Heterologous expression of individual Cav3 -subunits gives 
rise to currents which closely resemble native T-type Ca2+ currents, suggesting that auxiliary subunits 
are not required for assembly of functional Ca2+ channels, although other channel properties and 
trafficking may indeed be affected by the auxiliary subunits (Dolphin et al., 1999).  
T-type Ca2+ channels are widely distributed, but their physiological functions have sometimes proved 
difficult to resolve. This is certainly true in vascular smooth muscle cells (VSMCs), where Cav3.1 and 
Cav3.2 are expressed. Numerous attempts have failed to record “classic” T-type Ca2+ channel activity 
in VSMCs (reviewed in (Kuo et al., 2011;Kuo et al., 2014)). Recent studies suggest this is because 
VSMCs primarily express T-type Ca2+ channel splice variants which do not activate at the low 
voltages normally associated with T-type Ca2+ channels. Instead, they activate over more depolarised 
voltage ranges as are observed for L-type Ca2+ channels. Splice variation accounting for these 
differences occurs in Cav3.1 (and similarly in Cav3.2) primarily around exons 25 and 26, 
corresponding to the intracellular linker region between domains III and IV (Chemin et al., 
2001;Emerick et al., 2006;Latour et al., 2004). Four variants have been identified, termed 25a, 25b, 
25bc and 25ac, with variant 25bc predominating in both the juvenile and mature systemic 
vasculature. These variants all contribute to vasomotor tone (Kuo et al., 2011;Kuo et al., 2014), and 
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may also have a pacemaker role, controlling slow Ca2+ waves and contractile oscillations (Cribbs, 
2006).  
Despite continued uncertainty around the physiological roles of T-type Ca2+ channels in the 
vasculature, it appears that in several vascular diseases the influence of T-type Ca2+ channels, 
particularly Cav3.1, becomes more prominent. Their increased expression and activity appears to be 
instrumental in pathological vascular remodelling in both the systemic and pulmonary circulation, 
providing a route for Ca2+ entry which is required for proliferation (Tzeng et al., 2012;Chevalier et al., 
2014). Interestingly, numerous cancers also rely on the expression of T-type Ca2+ channels for 
proliferation, and hence tumour growth (Dziegielewska et al., 2014). These findings suggest that 
they represent a promising therapeutic target in the treatment of various cancers and cardiovascular 
diseases.   
In the nervous system, T-type Ca2+ channels serve better defined roles. Thus, for example, in 
thalamic and corticothalamic neurones T-type Ca2+ channels are responsible for pacemaker activity 
and low threshold spikes (Huguenard & Prince, 1994), as illustrated in the cartoon of Fig. 1E. They 
contribute to “rebound” bursts of spikes following a hyperpolarizing postsynaptic potential. Indeed, 
evidence suggests that all three isoforms of T-type Ca2+ channels can contribute to this excitability 
(Kim et al., 2001;Joksovic et al., 2006;Lee et al., 2014). In the peripheral nervous system, T-type Ca2+ 
channels are prominent in somatosensory fibres including small, capsaicin-sensitive (presumed 
nociceptive) dorsal root ganglion (DRG) neurons (Jevtovic-Todorovic & Todorovic, 2006;Nelson et al., 
2006;Rose et al., 2013) as well as in two distinct populations of low-threshold mechanoreceptors 
(LTMRs), A- and C-LTMRs, innervating skin hair follicles (Francois et al., 2015). Cav3.2 is the 
dominant form in DRG and may even be the exclusive form in some mechanosensitive neurons (Shin 
et al., 2003). They can control burst firing in DRG neurons (White et al., 1989) and so strongly 
influence excitability (Nelson et al., 2005;Nelson et al., 2007a), implying they are of central 
importance to nociception since stimulus intensity correlates with burst frequency. Indeed, the role 
of T-type Ca2+ channels in pain is well recognised and has been covered in depth in several recent 
reviews (Bourinet et al., 2014;Todorovic & Jevtovic-Todorovic, 2014;Francois et al., 2014;Waxman & 
Zamponi, 2014;Zamponi et al., 2015). Thus, conditional genetic deletion (Francois et al., 2015), or 
downregulation of Cav3.2 in DRG using intrathecal injection of antisense oligonucleotides (Bourinet 
et al., 2005;Messinger et al., 2009) produced strong anti-nociceptive effects in rodent pain models of 
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neuropathic and inflammatory pain. Conversely, T-type Ca2+ currents are often increased in 
pathological conditions associated with chronic pain, such as diabetic neuropathy (Jagodic et al., 
2007;Messinger et al., 2009), peripheral nerve injury or inflammation (Jagodic et al., 2008;Garcia-
Caballero et al., 2014;Marger et al., 2011). Both the enhancement of channel trafficking (Orestes et 
al., 2013;Weiss et al., 2013) and enhanced deubiquitination (Garcia-Caballero et al., 2014) were 
reported as underlying mechanisms for the latter phenomenon.  
It is not entirely clear how exactly T-type Ca2+ channels participate in the nociceptive transmission. 
Cav3.2 channel expression has been detected in different compartments of afferent fibers including 
peripheral nociceptive terminals and axons of skin afferents (Rose et al., 2013;Francois et al., 2015), 
nodes of Ranvier of A fibers (Francois et al., 2015) as well as in the presynaptic terminals of 
nociceptive fibers in the spinal cord ((Jacus et al., 2012) however, cf. Francois et al., 2015). 
Therefore, multiple mechanisms (or their combinations) are conceivable, including setting the 
threshold for action potential generation (at the nerve terminals) and propagation (at the nodes of 
thinly myelinated fibres), supporting burst firing, or indeed promoting synaptic activity at the central 
terminals of afferent fibres. Finally, since T-type Ca2+ channels are expressed in skin terminals of low 
threshold mechanoreceptors, including D-hair cells (Coste et al., 2007;Francois et al., 2015), a more 
direct role of T-type Ca2+ channels in mechanotransduction also cannot be excluded.     
In accordance with strong evidence for the physiological role of T-type Ca2+ channels in pain, recent 
data clearly demonstrated that pharmacological inhibition of T-type Ca2+ channel activity produces 
strong anti-nociceptive effects in various rodent pain models (Todorovic et al., 2001;Todorovic et al., 
2002;Todorovic et al., 2004;Latham et al., 2009). Together with N-type Ca2+ channels, T-type Ca2+ 
channels are clinically validated drug targets for pain (Bourinet et al., 2014). Accordingly, intense 
search is currently underway for novel pharmacological tools targeting T-type Ca2+ channel activity. 
These need to be more selective than widely used blockers such as mibefradil which, despite its 
ability to inhibit T-type Ca2+ channels, is not highly selective (Bezprozvanny & Tsien, 1995). This new 
generation of more selective T-type inhibitors (e.g. TTA-A2, TTA-P2, KYS-05090S) shows  promising 
analgesic properties in animal models of pain (Choe et al., 2011;Francois et al., 2013). Another novel, 
selective and orally bioavailable T-type Ca2+ channel blocker, Z944, which showed analgesic activity 
in animal models of inflammatory and neuropathic pain, is currently being tested in clinical trials as a 
first-in-class novel oral analgesic (Lee, 2014). Moreover, Zamponi’s lab has recently developed small 
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molecule modulators that prevent deubiquitination of the Cav3.2 channels by the deubiquitinase 
USP5, which in turn, can prevent channel upregulation in chronic pain conditions (Gadotti et al., 
2015). 
A redox- and Zn2+-sensitive ‘module’ within the Cav3.2 subunit  
Studies in both native DRG neurons and recombinant expression systems have revealed a regulatory 
site within Cav3.2 which confers high sensitivity to redox agents, distinguishing it functionally from 
both Cav3.1 and Cav3.3. Thus, for example, T-type Ca2+ currents recorded in native nociceptive 
neurones and recombinant Cav3.2 currents are enhanced by reducing agents (dithiothreitol (DTT) or 
L-cysteine) and inhibited by the oxidising agent 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) (Nelson et 
al., 2007a). Sensitivity to these agents was exploited in order to demonstrate the importance of 
Cav3.2 in nociception: hindpaw injections of DTT or L-cysteine induces thermal and mechanical 
hyperalgesia (Todorovic et al., 2001), and such effects are prevented with the Ca2+ channel inhibitor 
mibefradil; furthermore, analgesic effects are observed with DTNB (Todorovic et al., 2001). Such 
findings were confirmed in a subpopulation of nociceptive neurons expressing high levels of Cav3 
channels (Nelson et al., 2005). An important breakthrough in the field was achieved by the joint 
work of Perez-Reyes’ and Lee’s groups which allowed the characterization of specific Cav3.2 residues 
involved in the metal-induced inhibition of the Ca2+ channel. The redox-sensitive module is located 
extracellularly, involving interaction of the extracellular IS1-IS2 linker region with the IS3-IS4 linker 
region (Kang et al., 2010), the latter region containing a histidine residue (H191) which is key to 
conferring high redox sensitivity to this channel. Intriguingly, the same H191 residue that is involved 
in modulation of T-type Ca2+ channel activity by redox mechanisms also mediates T-type Ca2+ 
channel inhibition by low (sub-micromolar) concentrations of extracellular Zn2+ (Kang et al., 
2006;Kang et al., 2010). The full Zn2+ binding site also includes residues that precede H191, namely 
D189 and G190, as well as the negatively charged residues at the outer portion of the IS2 segment 
(Kang et al., 2010). It is, as yet, unclear how exactly the redox- and Zn2+-mediated modulatory 
pathways converge at the same site but one hypothesis suggests that H191 may represent a general 
binding site for transition metals (e.g. iron, copper, zinc) and can be subject to oxidation via a metal-
catalysed oxidation (MCO) reaction (Stadtman, 2001;Nelson et al., 2007a). It is conceivable therefore 
that either binding of metal (e.g. Zn2+) or Zn2+-independent MCO of H191 may result in a similar 
inhibition of channel activity. An alternative hypothesis is that oxidative modification (possibly but 
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not necessarily at H191) can increase the effect of metal binding either by increasing the affinity at 
the binding site or by enhancing coupling efficiency between the metal binding and channel 
inhibition. In such a scenario, oxidative modification could result in sensitization of the channel to 
Zn2+ (and potentially other transition metals) making the channel sensitive to ambient 
concentrations in biological fluids. Total Zn2+ concentration in human plasma is reported to be within 
the range of 5-20 M (Moran et al., 2012). Although it is likely that the free [Zn2+] is considerably 
lower, it is still quite plausible that the extracellular free [Zn2+] can reach the nanomolar range at 
which changes in Zn2+ affinity/sensitivity of Cav3.2 subunits may result in noticeable changes in 
channel activity. While the exact mechanism of regulation of Cav3.2 activity via the H191-containing 
regulatory site remains to be elucidated, it is clear that redox modulation is involved in the action on 
the T-type Ca2+ channels of some pharmacological agents and physiological signalling cascades 
including nitrous oxide (Orestes et al., 2011), CO and thioredoxin (Boycott et al., 2013), as well as 
GABAB receptors (Huang et al., 2015).   
H2S as a gasotransmitter  
H2S is regarded as the third ‘gasotransmitter’, since it is an endogenous, enzymatically-generated, 
biologically active gas. Emerging evidence indicates that it has widespread physiological and 
pathophysiological importance throughout the body (Li et al., 2011). Unsurprisingly, therefore, it has 
received increasing interest as a potential therapeutic target over the past decade or so, as was the 
case previously for both NO and CO (Leffler et al., 2006;Moore et al., 2003;Szabo, 2007). H2S is 
generated primarily by the action of two widely distributed enzymes, cystathionine lyase (CSE) and 
cystathionine  synthetase (CBS; Fig. 2). Both synthesise the gas from L-cysteine. More recently, the 
mitochondrially-located 3-mercaptopyruvate sulfurtransferase (3-MST) has also been found to 
generate H2S in both the brain and vasculature (Fig. 2). 3-MST generates H2S from 3-
mercaptopyruvate which is itself generated by cysteine aminotransferase (CAT; (Kimura, 2010)). Red 
blood cells can generate H2S non-enzymatically from inorganic polysulfides, a finding which has 
prompted the idea that H2S may mediate the beneficial vascular effects of dietary garlic (Benavides 
et al., 2007). H2S is also known to be liberated in a redox- or pH-sensitive manner from sulfur 
‘stores’; i.e. sulfur bound to proteins in mitochondria or the cytosol (Kimura, 2010). Differential 
distribution of H2S-generating enzymes results in a predomination of CBS in the central nervous 
system, along with 3-MST (Leffler et al., 2006); whereas CSE is dominant peripherally, generating the 
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majority of H2S elsewhere in the body, including the vasculature. More recently, H2S has been shown 
to be generated from D-cysteine (Fig. 2), particularly in the cerebellum and kidney, via a novel 
pathway involving 3-MST and D-amino acid oxidase (Shibuya et al., 2013).   
H2S as a regulator of ion channels 
Ion channels (specifically NMDA receptors; (Abe & Kimura, 1996)) were amongst the first family of 
cellular proteins recognized as being molecular targets of H2S. Since then, reports of ion channel 
regulation by H2S have grown rapidly (Peers et al., 2012;Kuksis & Ferguson, 2015;Zhang et al., 2015), 
as suggested in Fig. 2. It is clear that modulation by H2S is not confined to any particular class of ion 
channels (such as voltage- or ligand-gated channels) or to channels which are selective for specific 
ions (e.g. K+, Na+ , Ca2+ or Cl-)(Zhang et al., 2015). H2S is also known to interfere with a number of 
intracellular signalling pathways (Wang, 2012), and it is via these pathways that H2S, in some cases, 
modifies ion channel activity. In other cases, direct post-translational modification accounts for its 
effects. The best studied of these is the vascular smooth muscle ATP-sensitive K+ channel (KATP 
channel), which becomes more active when sulfhydrated (i.e. when –SH groups within cysteine 
residues are altered to –SSH groups). This direct process (also known as persulfidation; see (Paul & 
Snyder, 2015)) contributes to vasorelaxation and thereby protects against hypertension (Paul & 
Snyder, 2012;Mustafa et al., 2011).  
The list of ion channels regulated by H2S is long and continues to grow. However, some areas of 
contention have arisen along the way. Thus, for example, inhibition by H2S of the high-conductance, 
Ca2+-sensitive K+ channel has been described in detail (Telezhkin et al., 2010), yet others report 
activation of this channel by H2S (Sitdikova et al., 2010;Jackson-Weaver et al., 2013). Similarly, 
inhibition of L-type Ca2+ channels in cardiac myocytes (Sun et al., 2008;Avanzato et al., 2014) 
contrasts with the observed augmentation of L-type Ca2+ channel activity reported in astrocytes 
(Nagai et al., 2004). Such discrepancies may have simple explanations, but these need to be 
identified if H2S modulation of ion channels is to be exploited therapeutically. The remainder of this 
review is focussed on the known pro-algesic effects of H2S and considers the recent, conflicting data 
concerning the role of T-type Ca2+ channels in this process.  
H2S as a regulator of Cav3.2 
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Our group has recently reported an inhibitory effect of micromolar concentrations of H2S on 
recombinant and native T-type Ca2+ channels in sensory neurons (Elies et al., 2014).  Among Cav3 
subunits, this effect was selective to Cav3.2 while Cav3.1 and Cav3.3 were insensitive to H2S. In 
agreement with the predominant expression of Cav3.2 subunits in DRG neurons, H2S also strongly 
inhibited endogenous low-voltage activated (LVA) currents in these neurons. Interestingly, the same 
extracellular histidine residue H191, which is necessary for Cav3.2 modulation by Zn2+ and redox 
agents, was also found critical for the effect of H2S. Thus, an H191Q mutation in Cav3.2 abolished 
channel sensitivity to H2S and the analogous reciprocal mutation in Cav3.1 (Q172H) conferred 
sensitivity to H2S on this subunit (Elies et al., 2014). It is not entirely clear exactly how redox/Zn
2+-
binding of Cav3.2 is implicated in this H2S-mediated effect but one theory is that H2S may increase 
channel sensitivity to extracellular Zn2+. Indeed, chelation of ambient Zn2+ with TPEN (N,N,N',N'-
tetrakis(2-pyridylmethyl)ethane-1,2-diamine) fully reversed the H2S-mediated T-type Ca
2+ channel 
inhibition. Moreover, pre-treatment with TPEN abolished H2S-mediated inhibition when H2S was 
applied in the continued presence of TPEN. However, subsequent washing out of TPEN in the 
presence of H2S allowed the inhibition to commence (Elies et al., 2014). Thus, the action of H2S on 
Cav3.2 seems to depend on ambient Zn2+,
 assumed to be present in extracellular solutions in trace 
amounts. Indeed, according to our atomic absorption spectroscopy measurements, total Zn2+ levels 
can reach micromolar levels in nominally zinc-free laboratory solutions (Huang & Gamper, 
unpublished); likewise, micromolar concentrations of Zn2+ in plasma are also reported (Moran et al., 
2012). While levels of free Zn2+ are likely to be much lower as compared to the total zinc, it is still 
likely that this metal is present in the extracellular milieu at levels sufficient to affect channel 
activity. We hypothesize that the action of H2S results in the potentiation of channel inhibition by 
such ambient Zn2+, via a mechanism which may share commonalities with the redox modulation of 
Cav3.2 (see Abstract Figure).   
Although our data strongly suggest that H2S inhibits Cav3.2 and the endogenous T-type Ca
2+ currents 
in DRG neurons, there is an alternative theory suggesting that H2S augments T-type Ca
2+ currents, 
possibly by chelating Zn2+, and that this augmentation underlies the pro-algesic actions of this 
gasotransmitter (Matsunami et al., 2011;Kawabata et al., 2007;Takahashi et al., 2010;Maeda et al., 
2009). Thus, injection of the H2S-donor NaHS into the rat hindpaw produced hyperalgesia which was 
abolished by the oxidizing agent DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) and by the 
pharmacological inhibition of T-type Ca2+ channels (Kawabata et al., 2007). Inhibition of endogenous 
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H2S production also produced an anti-algesic effect. This and other studies by the same group led 
them to conclude that H2S could activate or “sensitize” Cav3.2 channels in order to account for its 
pro-algesic effects (Takahashi et al., 2010;Kawabata et al., 2007). Furthermore, H2S-induced colonic 
pain could be mimicked by chelation of Zn2+ (Matsunami et al., 2011). Yet, most of the evidence 
suggesting that pro-algesic effects of H2S are mediated by T-type Ca
2+ channel augmentation is 
somewhat circumstantial and direct electrophysiological evidence is sparse and insubstantial. For 
example, pre-incubation of NG108-15 cells with 1.5 mM NaHS resulted in ~20% augmentation of 
endogenous T-type Ca2+ current while at 0.5mM the effect was not significant (Kawabata et al., 
2007). Another study demonstrated that pre-incubation of HEK293 cells exogenously expressing 
Cav3.2 channels with the CSE inhibitor propargylglycine resulted in a reduction of the current, which 
was interpreted as tonic augmentation of recombinant Cav3.2 by endogenous H2S (Sekiguchi et al., 
2014). Interestingly, only in the presence of this inhibitor were currents augmented by NaHS. These 
experiments are consistent with potential augmentation of T-type Ca2+ currents by H2S but the 
following has to be taken into account: i) only very high, millimolar concentrations of NaHS were 
efficacious; ii) due to the experimental protocol used (pre-incubation) these experiments did not 
directly assess the acute effect of H2S on T-type Ca
2+ channel activity.  
In our hands, increasing the NaHS concentration to 3mM did augment recombinant Cav3.2 currents, 
while even higher concentrations were needed to significantly augment native T-type Ca2+ channel 
currents in DRG neurons (Elies et al., 2014). These experiments can, to some degree, reconcile 
conflicting experimental evidence from different laboratories and suggest a dual effect of H2S on T-
type Ca2+ channels: H191-mediated inhibition at low (micromolar) concentrations and potentiation 
(due to an unknown mechanism) at high (several mM) concentrations. It is important to point out, 
however, that the presence H2S at millimolar concentrations in mammalian tissues is highly unlikely. 
Initial reports estimated plasma H2S levels within the range of 20–100 M (Li and Moore, 2008), but 
even these values are now regarded as overestimations (Li et al., 2011). Therefore, physiologically 
relevant concentrations of H2S are unlikely to be sufficiently high to produce T-type Ca
2+ channel 
augmentation. The expected effect of endogenous H2S is, therefore, inhibition of T-type Ca
2+ channel 
currents, at least in cells and tissues that express significant amounts of Cav3.2 (such as sensory 
neurons). Therefore, the hypothesis that physiological levels of H2S can trigger pro-algesic effects via 
T-type Ca2+ channel activation appears questionable at present. Furthermore,  in our view, it is also 
unlikely that H2S can act as a Zn
2+ chelator (as was suggested by (Matsunami et al., 2011) as i) 
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chemical properties of H2S do not suggest metal chelating properties (e.g. the ability to form 
polydentate complexes); ii) acute application of H2S leads to T-type Ca
2+ channel current inhibition, 
whereas Zn2+ chelation with TPEN causes current augmentation (Nelson et al., 2007b;Elies et al., 
2014); iii) application of TPEN completely reverses H2S-induced T-type Ca
2+ channel inhibition; iv) 
pre-application of TPEN renders H2S unable to inhibit T-type Ca
2+ channels.  
At present, whilst it is hard to envisage how the painful / hyperalgesic effects of H2S (especially these 
of endogenously produced H2S) can be mediated by its effect on T-type Ca
2+ channels, other possible 
targets may account for this action. Thus, H2S was suggested to produce some of its pro-algesic 
effects via TRPA1 activation (Andersson et al., 2012;Hsu et al., 2013). Additionally, H2S was 
suggested to inhibit voltage-gated K+ channels in trigeminal sensory neurons (most likely Kv1.1 and 
Kv1.4) thus producing depolarizing and excitatory effects (Feng et al., 2013). 
Conclusions and perspectives 
Tonic H2S production clearly impacts a variety of both physiological and pathological processes, and 
likely does so in part via direct and indirect modulation of ion channel activity. The numerous and 
diverse pathways that can be modified by H2S suggest that interventional control of this 
gasotransmitter could be therapeutically beneficial (e.g. in the cardiovascular system and peripheral 
sensory neurones). However, conflicts have arisen and must be resolved. We believe that at least 
some issues could be rectified if the experimental conditions through which we study the effects of 
H2S are standardised (e.g. preparation of stock solutions of H2S donors, flow rates of solutions 
containing donors, exposure time, and obligatory use of agar bridges for reference electrodes).  
Twenty years after the discovery of H2S as an endogenously bioactive molecule (Abe & Kimura, 
1996), one of the main challenges within the field remains the measurement of absolute 
concentrations of H2S, in real time, both intracellularly and in extracellular compartments. For 
instance, development of appropriate intracellular fluorescence probes will expand not only the 
knowledge regarding intracellular concentrations of H2S in space and time, but it will also help to 
correlate experimental data obtained from exogenously-administered H2S with experimental data 
obtained from endogenously-generated H2S.  Additionally, future research regarding the 
physiological effects of H2S must bear in mind the crosstalk signalling with other gasotransmitters 
(NO and CO).  Only then can we obtain more comprehensive and uniformly acceptable data on 
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which to build in order to design modulators of H2S production and signalling for translational 
benefit.  
 
 
 
Figure legends 
Abstract Figure 
Cartoon showing the linear structure of the transmembrane domain I of the Cav3.2 T-type Ca2+ 
channel  subunit. In the ‘tonic’ channel state (middle), zinc partially occupies a binding site formed 
by interacting residues (indicated by white dots) present in IS1-IS2 and IS3-IS4 linkers, including 
H191. Under these conditions, zinc causes tonic inhibition of evoked currents (as illustrated by 
example current shown below). Chelation of zinc by TPEN (left) augments current amplitudes via 
relief of tonic zinc inhibition. In the presence of H2S, zinc affinity appears augmented, leading to 
increased zinc binding and a reduction in current amplitude.  
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Figure 1 
Properties of T-type Ca2+ channels. (A) Example currents evoked by step depolarizations applied 
(according to the protocol shown above each trace) to HEK293 cells expressing each of the 3 classes 
of T-type Ca2+ channel, as indicated. Note the relatively slow activation and inactivation of Cav3.3 as 
compared with Cav3.1 and Cav3.2. (B) Schematic current-voltage relationship typical of T-type Ca2+ 
channels; note the low threshold for activation. (C) Superimposition of steady state inactivation plot 
(solid line) and activation profile (dashed line) typical of T-type Ca2+ channels. Note the pronounced 
window current (region of overlap, arrowed). (D) Fluorimetric recording of [Ca2+]i in a Fura-2 loaded 
HEK293 cell expressing Cav3.2. For the period indicated by the shaded area, the T-type channel 
blocker mibefradil (1M) was applied, causing a reduction in basal [Ca2+]i (unpublished data). (E) 
Cartoon of membrane depolarizations evoked by current injections in thalamic neurones. Note the 
evoked burst activity is almost fully suppressed in cells lacking the T-type channel Cav3.1 (see Kim et 
al., 2001). 
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Figure 2. 
Hydrogen sulfide synthesis and effector ion channels. Schematic illustrating the synthesis of H2S 
from homocysteine, L- and D-cysteine via enzymes shown in boxes (CBS, cystathionine β synthase; 
CSE, cystathionine γ lyase; 3-MST, 3-mercaptopyruvate sulfurtransferase; CAT, cysteine 
aminotransferase; DAO, D-amino acid oxidase). Some of the target ion channels modulated by H2S 
are also indicated (NMDAR, N-methyl-D-aspartate receptor; VGCC, voltage-gated Ca2+ channel; TRP, 
Transient receptor potential channel).  
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